Compare HYFT & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HYFT | BTMD |
|---|---|---|
| Founded | 1983 | 2012 |
| Country | United States | United States |
| Employees | 102 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.9M | 72.7M |
| IPO Year | N/A | 2021 |
| Metric | HYFT | BTMD |
|---|---|---|
| Price | $1.76 | $2.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $5.00 | $2.83 |
| AVG Volume (30 Days) | ★ 448.7K | 216.3K |
| Earning Date | 03-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 722.22 |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $192,219,000.00 |
| Revenue This Year | N/A | $2.03 |
| Revenue Next Year | $29.18 | $6.58 |
| P/E Ratio | ★ N/A | $33.58 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.99 | $1.27 |
| 52 Week High | $3.00 | $4.75 |
| Indicator | HYFT | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 69.74 | 48.40 |
| Support Level | $1.56 | $1.97 |
| Resistance Level | $1.93 | $2.17 |
| Average True Range (ATR) | 0.16 | 0.14 |
| MACD | 0.05 | -0.02 |
| Stochastic Oscillator | 72.15 | 37.58 |
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.